Phase IIa Study of ALLN-346 (Engineered Urate Oxidase) in Subjects With Hyperuricemia, Gout and Chronic Kidney Disease

Clinical trial NCT04987294 · TERMINATED

Trial details

NCT number: NCT04987294
Sponsor: Allena Pharmaceuticals
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Hyperuricemia Gout Chronic Kidney Diseases

Start date: 2022-09-02
Primary completion: 2022-09-02
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.